Corporate News

Lincoln Pharmaceuticals to review quarterly results at board meeting on October 29, 2026 As On :22-Oct-26 15:30

Lincoln Pharmaceuticals Limited will hold a board meeting on Thursday, October 29, 2026, to consider and approve unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited. Trading window for the company's securities has been closed since October 1, 2026, and will reopen 48 hours after the results are generally available.